July 30, 2014
Pfizer announced an agreement to acquire Baxter International?s marketed vaccines for $635 million.
|
July 29, 2014
The regulatory filing marks the first step in the approval process toward making RTS,S available as an addition to existing tools currently recommended for malaria prevention.
|
July 28, 2014
Bristol-Myers Squibb and Ono Pharmaceutical will jointly develop and commercialize immuno-oncology drugs for Japan, South Korea, and Taiwan.
|
July 24, 2014
Sandoz is first to file for FDA approval of a biologic under the biosimilars pathway created in the Biologics Price Competition and Innovation Act of 2009.
|
July 22, 2014
Unique Pharmaceuticals has issued a voluntary recall of sterile compounded preparations, but aired concerns about FDA?s recall demand.
|
July 21, 2014
By:
Melanie Sena
AbbVie's relocation to Ireland following Shire's acquisition could lower its annual tax expense by as much as 7% over the next 15 years.
|
July 18, 2014
By:
Melanie Sena
AstraZeneca releases designs for its new Global R&D center and corporate headquarters in Cambridge, UK.
|
July 18, 2014
After rejecting several bids, Shire has agreed to a merger with AbbVie valued at almost $55 billion.
|
July 17, 2014
Baxter investigates root cause of cellulosic fibers and/or plastics in four lots of IV solutions.
|
|
